Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/15/2012CN102639143A Composition for treating or preventing diabetes comprising silk peptide as active ingredient
08/15/2012CN102639142A Inhibition of endosomal toll-like receptor activation
08/15/2012CN102639141A Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema
08/15/2012CN102639140A Novel peptides, process for preparation thereof, and use thereof
08/15/2012CN102639124A Transdermal therapeutic system for the administration of peptides
08/15/2012CN102639111A Ophthalmic preparations based on BDNF (brain-derived neurotrophic factor) and their use
08/15/2012CN102634492A Polyethylene glycol dog source urate oxidase analogue, and preparation method and applications thereof
08/15/2012CN102634479A Cell protective agent containing metallothionein
08/15/2012CN102633883A Fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded sequence and application of fusion protein
08/15/2012CN102633874A Chemical coupling matter of deletion-recombination human keratinocyte growth factor I type
08/15/2012CN102633873A Novel peptide, applications and preparation method thereof
08/15/2012CN102633867A Antigenically-changed enterotoxin C2 mutant, coding gene thereof, preparation thereof and application thereof
08/15/2012CN102633863A New approach to treat intraocular hypertension
08/15/2012CN102631671A Therapeutic vaccine for improving vaccine induced cytotoxicity T cellular reaction
08/15/2012CN102631669A Nutritional breast patch and preparation method thereof
08/15/2012CN102631668A Application of biomedical fibrin glue serving as medicament for treating lacrimal duct obstruction diseases
08/15/2012CN102631667A Nerve regeneration promotion injection and preparation method thereof
08/15/2012CN102631666A Preparation method for biological agent for preventing and controlling human papilloma virus infection
08/15/2012CN102631665A Pharmaceutical composition of alanyl glutamine injection and compound amino acid injection
08/15/2012CN102631664A Application of 3-amino-2-hydroxy-4-phenyl-valyl-isoleucine
08/15/2012CN102631663A Compound amino acid composition and preparation for treatment of male sterility, impotence and premature ejaculation
08/15/2012CN102631662A Composition with functions of protecting liver and relieving fatigue and preparation method of composition
08/15/2012CN102631328A Recombinant human antithrombosis protein lyophilized powder injection and preparation method thereof
08/15/2012CN102321156B Novel thymopentin compound and composition powder injection thereof
08/15/2012CN102198081B Leptin gel slow-release system and application thereof
08/15/2012CN102153653B Fusion protein of tumor blood vessel targeted polypeptide and tissue factor and preparation method thereof
08/15/2012CN101947312B Modified polyethylene glycol superoxide dismutase (mPEG-SOD) nanoemulsion capable of being directly externally used for skin and preparation method thereof
08/15/2012CN101947307B Applications of human placenta peptide in preparing drugs for treating dry eye syndrome and other ocular surface diseases
08/15/2012CN101891822B Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability
08/15/2012CN101831005B PH sensitive type chitosan derivant and application thereof in pharmaceutics
08/15/2012CN101822684B Compound combined preparation for preventing osteoarticular pain and preparation method thereof
08/15/2012CN101721687B Insulin-hydroxyapatite nano compound, preparation method and application thereof
08/15/2012CN101591377B Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof
08/15/2012CN101497656B Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof
08/15/2012CN101489579B Prophylactic or therapeutic agent for viral disease
08/15/2012CN101282741B Method for treating or preventing ischemia reperfusion injury or multi-organ failure
08/15/2012CN101265297B Alpha-synapse nucleoprotein and Sph1 interactive condition site and application thereof in screening Parkinson's disease medicament
08/15/2012CN101203251B 玻璃体可视化剂 Vitreous visualization agent
08/15/2012CN101080490B Improved mevalonate kinase
08/15/2012CN101056648B Application of [d-meala]3- [etval]4 cyclosporin in treating hepatitis c infection and medicine composition containing [d-meala]3- [etval]4 cyclosporin
08/15/2012CN101039953B Therapeutic and diagnostic agents
08/15/2012CN101022737B Anti-hypertensive functional food products
08/14/2012USRE43581 Peptide epitopes of apolipoprotein B
08/14/2012USRE43580 Nasal calcitonin formulations
08/14/2012US8244476 Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium
08/14/2012US8242257 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
08/14/2012US8242246 Chimeric peptides for the regulation of GTPases
08/14/2012US8242245 Fetal polypeptides from human liver
08/14/2012US8242241 Computationally designed inhibitors of amyloidosis
08/14/2012US8242240 Anti-inflammatory compounds and uses thereof
08/14/2012US8242239 MHC molecule-binding tumor-associated peptides
08/14/2012US8242114 Bonding tissues and cross-linking proteins with naphthalimide compounds
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242089 Sphingolipids polyalkylamine conjugates for use in transfection
08/14/2012US8242088 Carrier vectors through an epithelium with tight junctions
08/14/2012US8242084 Dimerized peptide
08/14/2012US8242083 Kinase substrates
08/14/2012US8242082 Antibacterial peptide
08/14/2012US8242081 Cell penetrating peptides for intracellular delivery of molecules
08/14/2012US8242080 Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface
08/14/2012US8242079 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
08/14/2012US8242078 Therapeutics to inhibit MLL-menin interaction for treating leukemia
08/14/2012US8242077 Biosensor
08/14/2012US8242076 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
08/14/2012US8242072 Methods of treating inflammation using soluble IL-17RA/RC fusion proteins
08/14/2012US8241901 Method of secretory expression of lysostaphin in Escherichia coli at high level
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241871 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
08/14/2012US8241856 Using filaggrin concentration in bodily fluids to diagnose arthritic disorders; immunoassay
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241692 Preparation of canola protein isolate involving isoelectric precipitation
08/14/2012US8241671 Biocompatible material and process for manufacturing the same
08/14/2012US8241670 Compositions capable of facilitating penetration across a biological barrier
08/14/2012US8241645 Vaccine
08/14/2012US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
08/14/2012US8241640 Pharmaceutical botulinum toxin compositions
08/14/2012US8241639 Extracellular domains of Epstein Barr Virus (EBV) tumor-associated latent membrane proteins
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012US8241626 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/14/2012US8241624 Method of disinfecting packages with composition containing peracid and catalase
08/14/2012CA2632078C Methods of inducing terminal differentiation
08/14/2012CA2575280C Novel processes for stereoselective synthesis of trans isatx 247
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2489705C Use of amide derivative of ge 2270 factor a3 for the treatment of acne
08/14/2012CA2486345C Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2452075C Sustained release delivery system
08/14/2012CA2451187C Zero-order prolonged release coaxial implants
08/14/2012CA2442300C Cd8.alpha. + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/14/2012CA2429954C Method for altering cell fate
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/14/2012CA2251544C Cystatin b mutants
08/14/2012CA2218166C Methods of inducing immune tolerance using immunotoxins
08/09/2012WO2012106725A2 Methods and compositions for treating occular disorders
08/09/2012WO2012106671A1 Psa capture agents, compositions, methods and preparation thereof
08/09/2012WO2012106581A1 Fxr inhibitor, bile acid sequestrant as combination therapy for cholesterol reduction
08/09/2012WO2012106463A2 Cardiotrophin related molecules for enhanced therapeutics
08/09/2012WO2012106461A2 Combination therapy for treatment of cancer
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 3163